Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof
US-12030880-B2 · Jul 9, 2024 · US
This page is not indexed by search engines while we improve data quality.
Wang Huting patents
Wang Huting is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wang Huting |
| Total patents | 7 |
| First publication | Jul 28, 2016 |
| Latest publication | Jul 9, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Sulfoximine compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof
US-2021300923-A1 · Sep 30, 2021 · US
Tricyclic compound for bromodomain-containing protein inhibitor and preparation pharmaceutical composition, and application thereof
US-2019040063-A1 · Feb 7, 2019 · US
Kinase activity regulating compound intermediates preparation method
US-2018346418-A1 · Dec 6, 2018 · US
Quinazoline derivative and preparation method therefor
US-9725439-B2 · Aug 8, 2017 · US
Kinase modulating compounds, compositions containing the same and use thereof
US-9550781-B2 · Jan 24, 2017 · US
Quinazoline derivative and preparation method therefor
US-2016214964-A1 · Jul 28, 2016 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co Ltd | 7 |
| Centaurus Biopharma Co Ltd | 5 |
| Lianyungang Runzhong Pharmaceutical Co Ltd | 5 |
| Shouyao Holdings Beijing Co Ltd | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co Ltd | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 6 |
| C07D471/04 | 3 |
| A61K31/437 | 3 |
| A61P35/02 | 3 |
| A61P9/10 | 2 |